NCT02535156|CompletedPhase 1/2
Loading search results
Sponsor study identifier
interventional
21
0 countries
N/A
Study Start
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2014
Actual (reported)Study Completion
January 2015
Actual (reported)Neurophysiological indices of self-monitoring were assessed in a group of patients with Schizotypal Personality Disorder (SPD) and a control group. Both groups were assessed after the administration of risperidone and placebo.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
January 2014
Actual (reported)January 2015
Actual (reported)August 22, 2015
Actual (reported)August 28, 2015
Actual (reported)Neurophysiological indices of self-monitoring (Error Related Negativity)
Amplitude of the Error Related Negativity was assessed prior to and 2 hours after treatment administration
During acute effects of pharmacological treatment (up to 2 hours)
Schizotypal Personality Disorder (SPD) patients. They received two interventions: risperidone 1 mg and placebo (lactose).
Control group consisting of healthy volunteers.They received two interventions: risperidone 1 mg and placebo (lactose).
1 mg Risperidone
Lactose Placebo
21 participants (actual enrollment reported by the registry).
First Submitted
August 22, 2015
First Posted
August 28, 2015
Study Start
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
January 2014
Actual (reported)Study Completion
January 2015
Actual (reported)Last Updated
August 11, 2017
Record last verified: 2017-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: